Is the manufacturer GMP approved?

Yes, the company has GMP approval by the SFDA of China.

Where are the products exported to?

Products have been sold to countries and regions in South America, Africa, Asia, Southeast Asia, Oceania, and the Middle East.

What is the average lead time for orders?

The average lead time is one month during peak season.

Compound Sodium Lactate Injection / Infusion

Name: Compound Sodium Lactate Injection / Infusion
Brand: Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
SKU: 896985275

Hebei, ChinaShijiazhuang No. 4 Pharmaceutical Co., Ltd.

US$0.17-0.20

20,000 Pieces

Sample price:US$0.10/piece.Request sample

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

Injection

Model NO.

100ml, 250ml, 500ml, 1000ml

Suitable for

Elderly, Adult

State

Liquid

Shape

Injection

Type

Inorganic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Drug Reg./Approval No.

20044961

Transport Package

Plastic Bottle

Specification

500ml 1000ml

Trademark

SHIMEN

Origin

Hebei

HS Code

3004909099

Production Capacity

1000000

Key features

Corrects Acid Toxicosis: Sodium lactate corrects metabolic acid toxicosis and helps restore electrolyte balance.

Adjusts Electrolyte Equilibrium: Indicated for adjusting the equilibrium of humor electrolyte acid and alkali.

Clear Liquid Form: Product is a colorless clear liquid suitable for injection and infusion.

GMP Approved Manufacturer: Manufactured by Shijiazhuang No.4 Pharmaceutical Co., Ltd. with SFDA GMP approval.

High Production Capacity: Yearly output exceeds 1200 million bottles including 40 million soft plastic bottles.

Global Market Presence: Products sold to South America, Africa, Asia, and other international regions.

Multiple Dosage Options: Available in 500 ml, 250 ml, and 100 ml specifications.

Established Manufacturer: Company established in 1948 with over 3000 employees and USD 58 million capital.

Company profile

Shijiazhuang No. 4 Pharmaceutical Co., Ltd.

Hebei, China

Business Type: Manufacturer/FactoryExport Year: 2002-01-01Nearest Port: Tianjin Xingang, Qingdao, ShanghaiAverage Response Time: ≤18hTerms of Payment: LC, T/TInternational Commercial Terms(Incoterms): FOB, CFR, CIF, CIP, EXW

AI-Powered supplier vetting

SummaryShijiazhuang No. 4 Pharmaceutical Co., Ltd. is a large, public pharmaceutical manufacturer based in Hebei, China. The company excels in producing infusion solutions and other pharmaceutical products, with advanced production lines and adherence to GMP standards. It holds ISO and GMP certifications, indicating a strong commitment to quality. The company has been exporting since 2002, with a portion of its sales derived from exports. It emphasizes innovation and customer satisfaction, with a growing reputation and numerous industry awards. However, specific details on financial credibility and customization capabilities are not fully disclosed.

Supplier typeShijiazhuang No. 4 Pharmaceutical Co., Ltd. is a large integrated pharmaceutical enterprise, engaging in manufacturing, R&D, and marketing.

CertificationsThe supplier holds ISO 9001, ISO 14001, and GMP certifications, indicating adherence to international management, environmental, and production standards.

After-Sales capabilityThe supplier emphasizes providing superior service concepts and measures, ensuring product quality and patient health.

R&D capabilityThe company integrates advanced technology into its production and emphasizes continuous improvement, indicating strong innovation capabilities.

Production capacityThe supplier has a large-scale production capacity with advanced lines for various pharmaceutical products, leading in the domestic market.